CIK 0001500198
- Non-accelerated filer
- Smaller reporting company
NEUROONE MEDICAL TECHNOLOGIES Corp
Sign in to watch- Ticker
- NMTC
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270863354
- Phone
- +1 952-426-1383
- Business address
- 7599 ANAGRAM DR, EDEN PRAIRIE, MN, 55344
- Former names
- Original Source Entertainment, Inc.
- Open-market buys, last 90 days
- $66,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$66,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 5 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-21 | McClurg Ronald W. Chief Financial Officer | Grant or award | +12,500 | 79,500 | ||
| 2023-04-21 | McClurg Ronald W. Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +12,500 | 12,500 | ||
| 2023-04-21 | Mertens Steve Chief Technology Officer | Grant or award | +50,000 | 85,444 | ||
| 2023-04-21 | Mertens Steve Chief Technology Officer | Grant or award · Option to Purchase Common Stock | +50,000 | 50,000 | ||
| 2023-04-21 | Christianson Mark Business Development Director | Grant or award | +14,000 | 351,404 | ||
| 2023-04-21 | Christianson Mark Business Development Director | Grant or award · Option to Purchase Common Stock | +14,000 | 14,000 | ||
| 2023-04-21 | Rosa David A CEO and President | Grant or award | +91,500 | 550,119 | ||
| 2023-04-21 | Rosa David A CEO and President | Grant or award · Option to Purchase Common Stock | +91,500 | 91,500 | ||
| 2023-03-31 | Mertens Steve Chief Technology Officer | Shares withheld for taxes | −252 | $1.61 | $406 | 35,444 |
| 2023-03-31 | Christianson Mark Business Development Director | Shares withheld for taxes | −90 | $1.61 | $145 | 337,404 |
| 2023-03-31 | Rosa David A CEO and President | Shares withheld for taxes | −2,239 | $1.61 | $4K | 458,619 |
| 2023-03-23 | Christianson Mark Business Development Director | Sale | −12,711 | $1.50 | $19K | 337,494 |
| 2023-03-22 | Christianson Mark Business Development Director | Sale | −11,667 | $1.51 | $18K | 350,205 |
| 2023-03-21 | Christianson Mark Business Development Director | Sale | −2,122 | $1.60 | $3K | 361,872 |
| 2023-03-16 | Andrle Edward Director | Grant or award | +20,576 | 64,225 | ||
| 2023-03-16 | Andrle Edward Director | Grant or award · Option to Purchase Common Stock | +18,927 | 18,927 | ||
| 2023-03-16 | BUCKMAN PAUL Director | Grant or award | +20,576 | 81,248 | ||
| 2023-03-16 | BUCKMAN PAUL Director | Grant or award · Option to Purchase Common Stock | +18,927 | 18,927 | ||
| 2023-03-16 | MATHIESEN JEFFREY S Director | Grant or award | +20,576 | 86,636 | ||
| 2023-03-16 | MATHIESEN JEFFREY S Director | Grant or award · Option to Purchase Common Stock | +18,927 | 18,927 |
Page 9 of 13 · 243 trades